DAPAglifozin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DAPAglifozin, covering 2016-02-19 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes [Phase 1]